Loading…

Unapproved dermatologic indications for H2 receptor antagonists, cromolyn sodium, and ketotifen

Saved in:

Bibliographic Details
Published in:	Clinics in dermatology 2000, Vol.18 (1), p.103-111
Main Authors:	Paquette, Dana, Rothe, Marti Jill
Format:	Article
Language:	English
Subjects:	Anti-Asthmatic Agents - therapeutic use Cimetidine - therapeutic use Cromolyn Sodium - therapeutic use Dermatologic Agents - therapeutic use Drug Approval Drug Utilization Histamine H1 Antagonists - therapeutic use Histamine H2 Antagonists - therapeutic use Humans Ketotifen - therapeutic use Ranitidine - therapeutic use Skin Diseases - drug therapy United States United States Food and Drug Administration
Citations:	Items that this one cites Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

cited_by	cdi_FETCH-LOGICAL-c361t-7966fdd6a58bcfaede3faf801a305e7dcfbb86de1521f78e2b8ee7db6a714c8c3
cites	cdi_FETCH-LOGICAL-c361t-7966fdd6a58bcfaede3faf801a305e7dcfbb86de1521f78e2b8ee7db6a714c8c3
container_end_page	111
container_issue	1
container_start_page	103
container_title	Clinics in dermatology
container_volume	18
creator	Paquette, Dana Rothe, Marti Jill
description
doi_str_mv	10.1016/S0738-081X(99)00099-1
format	article
fullrecord	<record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70950733</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0738081X99000991</els_id><sourcerecordid>70950733</sourcerecordid><originalsourceid>FETCH-LOGICAL-c361t-7966fdd6a58bcfaede3faf801a305e7dcfbb86de1521f78e2b8ee7db6a714c8c3</originalsourceid><addsrcrecordid>eNqFkEtLAzEQgIMoWh8_QdmTKLia6bq7yUmk-ALBgxa8hWwykehuUpO00H9vbEW8ecqQ-eb1EXII9BwoNBfPtK1YSRm8nnB-SinlvIQNMgLW5gAq2CSjX2SH7Mb4nqFL2tBtsgO0pUA5jIiYOjmbBb9AXWgMg0y-929WFdZpq2Sy3sXC-FDcj4uACmcpx9Il-eadjSmeFSr4wfdLV0Sv7Xw4y1ldfGDyyRp0-2TLyD7iwc-7R6a3Ny-T-_Lx6e5hcv1YqqqBVLa8aYzWjaxZp4xEjZWRhlGQFa2x1cp0HWs0Qj0G0zIcdwzzd9fIFi4VU9UeOV73zbd8zjEmMdiosO-lQz-PoqW8zjqqDNZrMO8dY0AjZsEOMiwFUPFtVqzMim9tgnOxMisg1x39DJh3A-o_VWuVGbhaA5jPXFgMIiqLTqG2WVwS2tt_RnwB0d-L1A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70950733</pqid></control><display><type>article</type><title>Unapproved dermatologic indications for H2 receptor antagonists, cromolyn sodium, and ketotifen</title><source>ScienceDirect Freedom Collection 2022-2024</source><creator>Paquette, Dana ; Rothe, Marti Jill</creator><creatorcontrib>Paquette, Dana ; Rothe, Marti Jill</creatorcontrib><identifier>ISSN: 0738-081X</identifier><identifier>EISSN: 1879-1131</identifier><identifier>DOI: 10.1016/S0738-081X(99)00099-1</identifier><identifier>PMID: 10701091</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Anti-Asthmatic Agents - therapeutic use ; Cimetidine - therapeutic use ; Cromolyn Sodium - therapeutic use ; Dermatologic Agents - therapeutic use ; Drug Approval ; Drug Utilization ; Histamine H1 Antagonists - therapeutic use ; Histamine H2 Antagonists - therapeutic use ; Humans ; Ketotifen - therapeutic use ; Ranitidine - therapeutic use ; Skin Diseases - drug therapy ; United States ; United States Food and Drug Administration</subject><ispartof>Clinics in dermatology, 2000, Vol.18 (1), p.103-111</ispartof><rights>2000 Elsevier Science Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c361t-7966fdd6a58bcfaede3faf801a305e7dcfbb86de1521f78e2b8ee7db6a714c8c3</citedby><cites>FETCH-LOGICAL-c361t-7966fdd6a58bcfaede3faf801a305e7dcfbb86de1521f78e2b8ee7db6a714c8c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,4023,27922,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10701091$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Paquette, Dana</creatorcontrib><creatorcontrib>Rothe, Marti Jill</creatorcontrib><title>Unapproved dermatologic indications for H2 receptor antagonists, cromolyn sodium, and ketotifen</title><title>Clinics in dermatology</title><addtitle>Clin Dermatol</addtitle><subject>Anti-Asthmatic Agents - therapeutic use</subject><subject>Cimetidine - therapeutic use</subject><subject>Cromolyn Sodium - therapeutic use</subject><subject>Dermatologic Agents - therapeutic use</subject><subject>Drug Approval</subject><subject>Drug Utilization</subject><subject>Histamine H1 Antagonists - therapeutic use</subject><subject>Histamine H2 Antagonists - therapeutic use</subject><subject>Humans</subject><subject>Ketotifen - therapeutic use</subject><subject>Ranitidine - therapeutic use</subject><subject>Skin Diseases - drug therapy</subject><subject>United States</subject><subject>United States Food and Drug Administration</subject><issn>0738-081X</issn><issn>1879-1131</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><recordid>eNqFkEtLAzEQgIMoWh8_QdmTKLia6bq7yUmk-ALBgxa8hWwykehuUpO00H9vbEW8ecqQ-eb1EXII9BwoNBfPtK1YSRm8nnB-SinlvIQNMgLW5gAq2CSjX2SH7Mb4nqFL2tBtsgO0pUA5jIiYOjmbBb9AXWgMg0y-929WFdZpq2Sy3sXC-FDcj4uACmcpx9Il-eadjSmeFSr4wfdLV0Sv7Xw4y1ldfGDyyRp0-2TLyD7iwc-7R6a3Ny-T-_Lx6e5hcv1YqqqBVLa8aYzWjaxZp4xEjZWRhlGQFa2x1cp0HWs0Qj0G0zIcdwzzd9fIFi4VU9UeOV73zbd8zjEmMdiosO-lQz-PoqW8zjqqDNZrMO8dY0AjZsEOMiwFUPFtVqzMim9tgnOxMisg1x39DJh3A-o_VWuVGbhaA5jPXFgMIiqLTqG2WVwS2tt_RnwB0d-L1A</recordid><startdate>2000</startdate><enddate>2000</enddate><creator>Paquette, Dana</creator><creator>Rothe, Marti Jill</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>2000</creationdate><title>Unapproved dermatologic indications for H2 receptor antagonists, cromolyn sodium, and ketotifen</title><author>Paquette, Dana ; Rothe, Marti Jill</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c361t-7966fdd6a58bcfaede3faf801a305e7dcfbb86de1521f78e2b8ee7db6a714c8c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Anti-Asthmatic Agents - therapeutic use</topic><topic>Cimetidine - therapeutic use</topic><topic>Cromolyn Sodium - therapeutic use</topic><topic>Dermatologic Agents - therapeutic use</topic><topic>Drug Approval</topic><topic>Drug Utilization</topic><topic>Histamine H1 Antagonists - therapeutic use</topic><topic>Histamine H2 Antagonists - therapeutic use</topic><topic>Humans</topic><topic>Ketotifen - therapeutic use</topic><topic>Ranitidine - therapeutic use</topic><topic>Skin Diseases - drug therapy</topic><topic>United States</topic><topic>United States Food and Drug Administration</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Paquette, Dana</creatorcontrib><creatorcontrib>Rothe, Marti Jill</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Clinics in dermatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Paquette, Dana</au><au>Rothe, Marti Jill</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Unapproved dermatologic indications for H2 receptor antagonists, cromolyn sodium, and ketotifen</atitle><jtitle>Clinics in dermatology</jtitle><addtitle>Clin Dermatol</addtitle><date>2000</date><risdate>2000</risdate><volume>18</volume><issue>1</issue><spage>103</spage><epage>111</epage><pages>103-111</pages><issn>0738-081X</issn><eissn>1879-1131</eissn><cop>United States</cop><pub>Elsevier Inc</pub><pmid>10701091</pmid><doi>10.1016/S0738-081X(99)00099-1</doi><tpages>9</tpages></addata></record>
fulltext	fulltext
identifier	ISSN: 0738-081X
ispartof	Clinics in dermatology, 2000, Vol.18 (1), p.103-111
issn	0738-081X 1879-1131
language	eng
recordid	cdi_proquest_miscellaneous_70950733
source	ScienceDirect Freedom Collection 2022-2024
subjects	Anti-Asthmatic Agents - therapeutic use Cimetidine - therapeutic use Cromolyn Sodium - therapeutic use Dermatologic Agents - therapeutic use Drug Approval Drug Utilization Histamine H1 Antagonists - therapeutic use Histamine H2 Antagonists - therapeutic use Humans Ketotifen - therapeutic use Ranitidine - therapeutic use Skin Diseases - drug therapy United States United States Food and Drug Administration
title	Unapproved dermatologic indications for H2 receptor antagonists, cromolyn sodium, and ketotifen
url	http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T11%3A08%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Unapproved%20dermatologic%20indications%20for%20H2%20receptor%20antagonists,%20cromolyn%20sodium,%20and%20ketotifen&rft.jtitle=Clinics%20in%20dermatology&rft.au=Paquette,%20Dana&rft.date=2000&rft.volume=18&rft.issue=1&rft.spage=103&rft.epage=111&rft.pages=103-111&rft.issn=0738-081X&rft.eissn=1879-1131&rft_id=info:doi/10.1016/S0738-081X(99)00099-1&rft_dat=%3Cproquest_cross%3E70950733%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c361t-7966fdd6a58bcfaede3faf801a305e7dcfbb86de1521f78e2b8ee7db6a714c8c3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=70950733&rft_id=info:pmid/10701091&rfr_iscdi=true